Skip to main content
Log in

A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Previous work has shown that 6–12 months continuous trifluoperazine (TFP) administration to rats causes striatal dopamine receptor supersensitivity. We have now replicated our original findings in the striatum and report concurrent changes in mesolimbic dopamine function during chronic TFP (2.8–4.0 mg/kg/day) administration for 6 months. Initial inhibition of apomorphine-induced stereotyped behaviour, which lasted for 2 weeks after the beginning of drug administration, was replaced by an exaggerated response to apomorphine (0.5 mg/kg SC) after 6 months drug intake. Striatal dopamine sensitive adenylate cyclase activity was inhibited at 1 and 3 months, but by 6 months was enhanced compared to control values. Mesolimbic adenylate cyclase activity was inhibited after 2 weeks and thereafter returned to control levels. Dopamine-identified 3H-spiperone binding sites (Bmax) in the striatum were increased by 2 weeks, reduced at 1 month and increased again at 6 months. In mesolimbic areas Bmax was increased at 2 weeks and 1 month but thereafter returned to control levels. The dissociation constant (k D) of specific 3H-spiperone binding was increased in the striatum and mesolimbic areas at 1 month and 2 weeks respectively. The results show differential changes in dopamine function in striatal and mesolimbic brain areas during 6 months continuous TFP administration to rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Asper, H., Baggiolini, M., Burki, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptic catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur. J. Pharmacol. 22, 287–294 (1973)

    Google Scholar 

  • Carlsson, A.: Does dopamine play a role in schizophrenia? Psychol. Med. 7, 583–597 (1977)

    Google Scholar 

  • Carlsson, A., Lindqvist, M.: Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine. Acta Pharmacol. Toxicol. (Kbh.) 20, 140–144 (1965)

    Google Scholar 

  • Clow, A., Jenner, P., Theodorou, A., Marsden, C. D.: Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months. Nature 278, 59–61 (1979a)

    Google Scholar 

  • Clow, A., Jenner, P., Marsden, C. D.: Changes in dopamine mediated behaviour during one years neuroleptic administration. Eur. J. Pharmacol. 57, 365–375 (1979b)

    Google Scholar 

  • Clow, A., Theodorou, A. E., Jenner, P., Marsden, C. D.: Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. Eur. J. Pharmacol. 63, 135–144 (1980)

    Google Scholar 

  • Costall, B., Marsden, C. D., Naylor, R. J., Pycock, C. J.: Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res. 123, 89–111 (1977)

    Google Scholar 

  • Crow, T. J., Deakin, J. F. W., Longden, A.: The nucleus accumbens: Possible site of antipsychotic action of neuroleptic drugs? Psychol. Med. 7, 213–221 (1977)

    Google Scholar 

  • Davis, K. L., Hollister, L. E., Fritz, W. C.: Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol. Life Sci. 23, 1543–1548 (1978)

    Google Scholar 

  • Gianutsos, G., Moore, K. E.: Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine. Live Sci. 20, 1585–1591 (1977)

    Google Scholar 

  • Hitri, A., Weiner, W. J., Borison, R. L., Diamond, B. I., nausieda, P. A., Klawans, H. L.: Dopamine binding following prolonged haloperidol pretreatment. Ann. Neurol. 3, 134–140 (1978)

    Google Scholar 

  • Jackson, D. M., Andén, N., Engel, E., Liljequist, S.: The effect of longterm penfluridol treatment on the sensitivity of dopamine receptors in nucleus accumbens and in the corpus striatum. Psychopharmacologia 45, 151–155 (1975)

    Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data. Neuroleptic activity spectra for rats. Arzneim. Forsch. 15, 104–112 (1965)

    Google Scholar 

  • Kaneno, S., Watanabe, S., Toru, M., Shimazono, Y.: Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine. Brain Res. 152, 396–400 (1978)

    Google Scholar 

  • Klawans, M. D., Jr.: The pharmacology of tardive dyskinesias. Am. J. Psychiatry 130, 82–86 (1973)

    Google Scholar 

  • Leysen, J. E., Gommeren, W., Laduron, P. M.: Spiperone: A ligand of choice for neuroleptic receptors. Kinetics and characteristics of in vitro binding. Biochem. Pharmacol. 27, 307–316 (1978a)

    Google Scholar 

  • Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., Laduron, P. M.: Serotonergic component of neuroleptic receptors. Nature 272 168–171 (1978b)

    Google Scholar 

  • Marsden, C. D., Tarsy, D., Baldessarini, R. J.: Spontaneous and drug-induced movement disorders in psychotic patients. In: Psychiatric aspects of neurologic disease, D. F. Benson, D. Blumer, eds., pp. 219–265. New York: Grune and Stratton 1975

    Google Scholar 

  • Miller, R. J., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine-stimulated adenosine 3,5-monophosphate production in rat neostriatum and limbic forebrain. Mol. Pharmacol. 10, 759–766 (1974)

    Google Scholar 

  • Muller, P., Seeman, P.: Brain neurotransmitter receptors after longterm haloperidol: Dopamine, acetylcholine, serotonin, α-adrenergic and naloxone receptors. Life Sci. 21, 1751–1758 (1977)

    Google Scholar 

  • Sayers, A. C., Burki, H. R., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 41, 97–104 (1975)

    Google Scholar 

  • Scatton, B.: Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur. J. Pharmacol. 46, 363–369 (1977)

    Google Scholar 

  • van Rossum, J. M.: Significance of dopamine-receptor blockade for mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. Ther. 160, 492–494 (1966)

    Google Scholar 

  • Waldmeier, P. C., Maitre, L.: Clozapine: Reduction of the initial dopamine turnover increase by repeated treatment. Eur. J. Pharmacol. 38, 197–203 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clow, A., Theodorou, A., Jenner, P. et al. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration. Psychopharmacology 69, 227–233 (1980). https://doi.org/10.1007/BF00433087

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00433087

Key words

Navigation